Ngā hua rapu - Juraj Adamik
- E whakaatu ana i te 1 - 12 hua o te 12
-
1
829 Tumor alpha-fetoprotein inhibits cholesterol and steroid metabolism in monocyte-derived dendritic cells mā Lisa Butterfield, Juraj Adamik, Paul Munson
I whakaputaina 2020-11-01Tuhinga -
2
667 Tumor-derived alpha-fetoprotein requires polyunsaturated fatty acids for immuno-metabolic dysregulation mā Lisa Butterfield, Juraj Adamik, Paul Munson
I whakaputaina 2021-11-01Tuhinga -
3
Epigenetic‐Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease mā Juraj Adamik, G David Roodman, Deborah L Galson
I whakaputaina 2019-03-01
Tuhinga -
4
Osteoblast suppression in multiple myeloma bone disease mā Juraj Adamik, Deborah L Galson, G David Roodman
I whakaputaina 2018-11-01
Tuhinga -
5
-
6
The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis mā Konstantinos Lontos, Juraj Adamik, Anastasia Tsagianni, Deborah L. Galson, John M. Chirgwin, Attaya Suvannasankha
I whakaputaina 2018-06-01
Tuhinga -
7
-
8
-
9
Distinct mechanisms for induction and tolerance regulate the immediate early genes encoding interleukin 1β and tumor necrosis factor α. mā Juraj Adamik, Kent Z Q Wang, Sebnem Unlu, An-Jey A Su, Gillian M Tannahill, Deborah L Galson, Luke A O'Neill, Philip E Auron
I whakaputaina 2013-01-01
Tuhinga -
10
Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells mā Juraj Adamik, Paul V. Munson, Felix J. Hartmann, Alexis J. Combes, Philippe Pierre, Matthew F. Krummel, Sean C. Bendall, Rafael J. Argüello, Lisa H. Butterfield
I whakaputaina 2022-09-01
Tuhinga -
11
XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the Runx2 Gene in Pre-osteoblasts to Overcome Differentiation Suppression mā Juraj Adamik, Rebecca Silbermann, Rebecca Silbermann, Silvia Marino, Quanhong Sun, Judith L. Anderson, Dan Zhou, Xiang-Qun Xie, G. David Roodman, G. David Roodman, Deborah L. Galson
I whakaputaina 2018-06-01
Tuhinga -
12
704 Biological activity of FLX475, an oral CCR4 antagonist, as monotherapy and in combination with pembrolizumab in advanced cancer mā Qingfeng Zhu, Robert Anders, Damian Trujillo, Dirk G Brockstedt, Michael Chisamore, Juraj Adamik, Paul D Kassner, William Ho, Rakesh Kumar Goyal, Adam Grant, Shoji Ikeda, Marvin Au, Denise Nagata, Eugene Lurie, Mohsen Sabouri Ghomi
I whakaputaina 2023-11-01Tuhinga